Tag Archives: Khiron Life Sciences

Medical Cannabis Symposium

Khiron Receives Cultivation Quota From Colombian Government and Commences Cultivation

Khiron Receives Cultivation Quota From Colombian Government and Commences Cultivation

TORONTO, Ontario, Dec. 28, 2017 /Weed Wire/ — Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports that the Company’s wholly owned subsidiary, Khiron Colombia SAS, has commenced cultivation of a variety of medical grade cannabis strains in accordance with the receipt of its medical cannabis quota allocation provided by the Government of Colombia.

Medical Cannabis Symposium

Adent and Khiron Announce Letter of Intent for Proposed Business Combination

TORONTO, Ontario, Oct. 26, 2017 /Weed Wire/ – Khiron Life Sciences Corp. (“Khiron”) and Adent Capital Corp. (“Adent”) (NEX: ANT.H) report that the parties have entered into an arm’s length non-binding letter of intent (the “Letter of Intent”) dated October 25, 2017 in respect of a proposed business combination (the “Proposed Transaction”) that would result in the takeover of Adent by Khiron.

Medical Cannabis Symposium

Khiron Advisor Featured as Part of Joint Investigation by 60 Minutes and the Washington Post on U.S. Opioid Crisis

TORONTO, Ontario, Oct. 13, 2017 /Weed Wire/ — Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports that Matthew Murphy, Security and Compliance Advisor to Khiron, and former U.S. DEA Chief of Pharmaceutical Investigations, will be featured as part of a 60 Minutes and Washington Post joint investigation on the U.S. opioid crisis.


Top